| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate… |
Trial completed |
| 2026-08-11 | NCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate… |
Enrollment increased: 230 -> 255 participants |
| 2026-08-11 | NCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate… |
Trial sites expanded: 26 -> 69 locations |
| 2026-08-11 | NCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate… |
date change Primary completion pushed: 2025-11-24 -> 2026-05-14 |
| 2026-08-11 | NCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate… |
date change Completion pushed: 2025-12-08 -> 2026-05-14 |
| 2026-08-05 | NCT07010471 A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and… |
Enrollment closed, study ongoing |
| 2026-08-04 | NCT07287163 Clinical Trial of Vormatrigine in Adult Patients With Epilepsy |
Trial sites expanded: 20 -> 36 locations |
| 2026-08-04 | NCT07505004 Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults… |
Enrollment closed, study ongoing |
| 2026-08-04 | NCT05737784 A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A… |
Enrollment closed, study ongoing |
| 2026-08-04 | NCT05737784 A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A… |
date change Primary completion pushed: 2025-08 -> 2026-04-01 |
| 2026-08-04 | NCT05737784 A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A… |
date change Completion pushed: 2027-09 -> 2028-02 |
| 2026-08-04 | NCT07019922 A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety |
date change Primary completion pushed: 2026-06 -> 2026-12 |
| 2026-08-04 | NCT06840925 A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628 |
Completed without a posted recruiting period |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07019922 | A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety | Epileptic Encephalopathy | Recruiting |
| NCT06087276 | Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of… | Essential Tremor | Active, Not Recruiting |
| NCT07287163 | Clinical Trial of Vormatrigine in Adult Patients With Epilepsy | Epilepsy, Tonic-Clonic | Enrolling by Invitation |
| NCT07505004 | Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults… | Focal Epilepsy | Active, Not Recruiting |
| NCT07010471 | A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and… | Developmental and Epileptic Encephalopathy 1 | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05818553 | A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic… | SCN2A Encephalopathy | Active, Not Recruiting |
| Phase 2 | |||
| NCT06908356 | An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal… | Focal Onset Seizure | Recruiting |
| Phase 1/2 | |||
| NCT05737784 | A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A… | SCN2A-DEE | Active, Not Recruiting |